228 related articles for article (PubMed ID: 37427232)
1. Vitamin D and polycystic ovary syndrome (PCOS): a review.
Mohan A; Haider R; Fakhor H; Hina F; Kumar V; Jawed A; Majumder K; Ayaz A; Lal PM; Tejwaney U; Ram N; Kazeem S
Ann Med Surg (Lond); 2023 Jul; 85(7):3506-3511. PubMed ID: 37427232
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
Song DK; Lee H; Hong YS; Sung YA
BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and Polycystic Ovary Syndrome: a Narrative Review.
Mu Y; Cheng D; Yin TL; Yang J
Reprod Sci; 2021 Aug; 28(8):2110-2117. PubMed ID: 33113105
[TBL] [Abstract][Full Text] [Related]
6. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.
Dasgupta S; Dutta J; Annamaneni S; Kudugunti N; Battini MR
Indian J Med Res; 2015 Sep; 142(3):276-85. PubMed ID: 26458343
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Relationship between Body Mass Index with
Aghadavod E; Mollaei H; Nouri M; Hamishehkar H
Int J Fertil Steril; 2017; 11(2):105-111. PubMed ID: 28670428
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review.
Reis GV; Gontijo NA; Rodrigues KF; Alves MT; Ferreira CN; Gomes KB
J Obstet Gynaecol Res; 2017 Mar; 43(3):436-446. PubMed ID: 28127831
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome.
Di Bari F; Catalano A; Bellone F; Martino G; Benvenga S
Metabolites; 2021 Feb; 11(2):. PubMed ID: 33670644
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
11. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome.
El-Shal AS; Shalaby SM; Aly NM; Rashad NM; Abdelaziz AM
Mol Biol Rep; 2013 Nov; 40(11):6063-73. PubMed ID: 24078159
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of the roles of Inositol and Vitamin D in improving fertility among patients with Polycystic Ovary Syndrome.
Katyal G; Kaur G; Ashraf H; Bodapati A; Hanif A; Okafor DK; Khan S
Clin Exp Reprod Med; 2024 Apr; ():. PubMed ID: 38599886
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome.
Behmanesh N; Abedelahi A; Charoudeh HN; Alihemmati A
Turk J Obstet Gynecol; 2019 Sep; 16(3):143-150. PubMed ID: 31673465
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
18. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
Reprod Biol Endocrinol; 2018 Apr; 16(1):38. PubMed ID: 29669566
[TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
20. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
